For over 15 years, the Indivumed Standard for Biobanking has been firmly established and acknowledged as synonymous with unparalleled quality.
We are globally recognized and trusted as setting the highest standard for biospecimen and clinical data collection. We offer a wide range of biobank products to support your research and development in personalized medicine, biomarker validation, drug discovery, and companion diagnostics.
Indivumed provides a broad spectrum of systematic sample quality and clinical data with Premium Grade, Advanced Grade, and Basic Grade samples from the most stringent requirements to routine and standard operations.
Indivumed is known for the ultimate quality of biospecimens with a minimized biospecimen usability failure rate of less than 1% for our Premium Grade and less than 5% for our Advanced and Basic Grade biospecimens. Our capability is to accelerate your time to market without having to compromise on quality and clinical data integrity.
With clinical data’s potential to help detect trends and potential causes of cancer, we consider our extensive collection one of our greatest assets.
The clinical data sets that Indivumed provides stem from fully consenting and informed patients and their medical records, notes taken during surgical tumor resection, and comprehensive interviews with the patient and his or her physician. Following surgery, long-term and follow-up data are collected annually.
For every patient, we document approximately 320 data points. All available data is thoroughly cross-checked in regard to completeness, correctness, and plausibility before being stored in Indivumed’s Oracle-based database, IndivuNET.
Four different types of clinical data sets are available for Premium and Advanced Grade Biospecimens:
Basic Data includes general patient data, current disease, surgical findings, tumor size, and ischemia time, and classification.
Comprehensive Data includes basic data and extended patient data, current medications, drug intolerances, addictive drugs, previous diseases, neoadjuvant therapies, previous surgeries, previous cancer, family history, and presurgical diagnostics.
Follow-up Data includes basic and comprehensive data along with FUP medications, chemotherapies, radiation therapies, hormone therapies, targeted therapies, and diagnostic procedures.
Additional Data includes information on MSI/MSS, biomarkers, and infection status.
|Our team will assist you in selecting the most suitable biospecimen for your needs.||REQUEST A QUOTE|